Defects of insulin signaling therefore result in insulin resistance, alterations in glucose tolerance, and vascular endothelial dysfunction, which is often seen in the metabolic syndrome, a cluster of cardiovascular risk factors (Yu et al., 2011). This evidence concerns the gene INS and metabolic syndrome.